Close Menu

NEW YORK (GenomeWeb) — Canine consumer genomics firm Embark Veterinary said today that it has closed a $10 million Series A financing round.

The round was led by F-Prime Capital and included existing investors Slow Ventures, Section 32, Third Kind Venture Capital, Freestyle Capital, FJ Labs, and 23andMe CEO Anne Wojcicki. It follows a $4.5 million funding round in mid-2017.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.